Cesca Therapeutics Inc. | Mutual Funds
Mutual Funds that own Cesca Therapeutics Inc.
Vanguard Extended Market Index Fund
58,940
0.28%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
39,860
0.19%
0
0%
07/31/2018
Vanguard Balanced Index Fund
28,650
0.14%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
12,204
0.06%
0
0%
07/31/2018
DFA Tax Managed US Targeted Value Portfolio
5,968
0.03%
0
0%
04/30/2018
DFA US Core Equity 2 Portfolio
5,400
0.03%
0
0%
04/30/2018
Fidelity Nasdaq Composite Index
5,298
0.03%
0
0%
07/31/2018
4,883
0.02%
0
0.01%
09/05/2018
Fidelity Spartan Total Market Index Fund
793
0%
0
0%
07/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
640
0%
0
0%
06/30/2018
| Address |
2711 Citrus Road
Rancho Cordova California 95742
United States
|
|
Employees
|
- |
| Website |
http://www.cescatherapeutics.com |
| Updated |
07/08/2019 |
| Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. |
